Navigation Links
Elixir Pharmaceuticals Announces Clinical Data at American Diabetes,Association Conference Highlighting Ability of Glufast to Maintain,Glycemic Control in Patients with Type 2 Diabetes

hibitors. The Company's own R&D efforts and those of its numerous research partners utilizing modulators of SIRT1 (a human sirtuin) have extended the SIRT knowledge base significantly in recent years. Elixir is also actively pursuing drug discovery efforts focused on other key targets, such as AMP-activated kinase (AMPK), which Elixir has shown to be implicated in the regulation of aging and metabolism in a variety of organisms.

More information about Elixir is available at http://www.elixirpharm.com/

Contact

Elixir Pharmaceuticals
William Heiden, 617-995-7000
or
Media:
Burns McClellan for Elixir Pharmaceuticals
Justin Jackson
jjackson@burnsmc.com
or
Jason Farber
jfarber@burnsmc.com
or
Investors:
Juliane Snowden
jsnowden@burnsmc.com
or
Nicki Kahner
nkahner@burnsmc.com
212-213-0006


'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. Elixir Pharmaceuticals Presents Preclinical Data Highlighting Its Ghrelin Antagonist Program at the American Diabetes Associations Annual Meeting
2. Elixir Pharmaceuticals Presents Additional Preclinical Data Demonstrating the Potential of Ghrelin Antagonism to Regulate Metabolism, Body Weight and Glycemic Control
3. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
4. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
5. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
6. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
7. Sunesis Pharmaceuticals to Present at the C. E. Unterberg, Towbin Emerging Growth Conference
8. EPIX Pharmaceuticals to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
9. Pro-Pharmaceuticals Updates Progress of Clinical Trials & Davanat 505 (b)(2) Filings
10. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
11. Portola Pharmaceuticals Announces Positive Phase II EXPERT Results and Additional Oral and Poster Presentations at the XXI Congress of the International Society on Thrombosis and Haemostasis (ISTH)

Post Your Comments:
(Date:11/25/2009)...HO CORDOVA, Calif., Nov. 25 AMPAC ... Pacific Corporation (Nasdaq: APFC ) announced to...ity and Sustainability Award at the Annual Statewi...ia Manufacturers and Technology Association (CMTA)...nd the Chemical Industry Council of California (CI...
(Date:11/25/2009)... CITY, Calif., Nov. 25 A...ompany manufacturing point-of-care blood analysis ...rman and chief executive officer, will present at ...ce on Wednesday, December 2, 2009 at 2:00 p.m. ET....e Hotel in New York City. ,, About Abaxis ,...
(Date:11/25/2009)..., NEW YORK, Nov. 25 Reportlinker.c...available in its catalogue: ,, Pain Managemen....com/p0164220/Pain-Management---Global-Trends.html...emergence of pain management clinics, and the adve...h in the pain management market. Healthcare reform...
Breaking Medicine Technology:AMPAC Fine Chemicals Receives Prestigious Award at California's Annual Statewide Environmental Summit 2AMPAC Fine Chemicals Receives Prestigious Award at California's Annual Statewide Environmental Summit 3Reportlinker Adds Pain Management - Global Trends 2Reportlinker Adds Pain Management - Global Trends 3Reportlinker Adds Pain Management - Global Trends 4Reportlinker Adds Pain Management - Global Trends 5Reportlinker Adds Pain Management - Global Trends 6Anticancer compound found in American mayapple 9798 1Anticancer compound found in American mayapple 9798 2For peats sake 3A Alternative growing media 9796 1For peats sake 3A Alternative growing media 9796 2Biophysical Society Announces 2010 society fellows 9794 1
...el includes data showing 35% reduction in new clin...following a recent hip ...osteoporosis treatment following hip fractu...,- Safety and efficacy profile of Reclast, already...eoporosis(1), reinforced in revised label, EAST H...
... N.Y., June 4 Ion-channel research is,drawing inc...nce,investigators all over the globe, reports Gene... interest is not surprising as ion channels,play k...neural signal,transduction, cardiac, skeletal, and...rt of nutrients and ions, among others, according ...
Other Medicine Technology:FDA Broadens US Indication for Once-Yearly Reclast(R) as Only Osteoporosis Treatment Approved for Prevention of Fractures After a Hip Fracture 2FDA Broadens US Indication for Once-Yearly Reclast(R) as Only Osteoporosis Treatment Approved for Prevention of Fractures After a Hip Fracture 3FDA Broadens US Indication for Once-Yearly Reclast(R) as Only Osteoporosis Treatment Approved for Prevention of Fractures After a Hip Fracture 4FDA Broadens US Indication for Once-Yearly Reclast(R) as Only Osteoporosis Treatment Approved for Prevention of Fractures After a Hip Fracture 5FDA Broadens US Indication for Once-Yearly Reclast(R) as Only Osteoporosis Treatment Approved for Prevention of Fractures After a Hip Fracture 6FDA Broadens US Indication for Once-Yearly Reclast(R) as Only Osteoporosis Treatment Approved for Prevention of Fractures After a Hip Fracture 7Genetic Engineering & Biotechnology News Reports on the Growing Role of Ion-Channel Studies in Global Biotech R&D 2
(Date:11/28/2009)... variation believed to affect circadian rhythm,...-- New research suggests that an internal body clo... development of bipolar disorder in children. ,...genetic makeup of 152 children with bipolar disord...d swings, and 140 children without the disorder. T...
(Date:11/27/2009)...AS, Nov. 27 Considered ... only 25 years ago, solid organ transplantation is...the extraordinary men and women who gathered at th...rs came together from medical centers around the w...egional Transplant Institute (BRTI), one of the pi...
(Date:11/27/2009)... XenaCare Holdings has announced that it ...ndation, one of the largest nonprofit organization...h education. , Delray Bea...ngs, Inc. (OTCBB: XCHO), a company specializing in... healthcare products, has announced today that is ...
(Date:11/27/2009)... Multi-purpose bilingual coloring books d...e by the business community to educate - inform pa...from Safety issues to Dinosuars to ABC,S and a hos...t Louis, MO (PRWEB) November 27, 2009 -- Today&rsq...toys to keep them busy any hour of the day, but on...
(Date:11/26/2009)... years, the number of Americans living with diabet...n in 2009 to 44.1 million in 2034. Over the same p...sing from $113 billion to $336 billion, even with ...ers based at the University of Chicago report in t...er of those with diabetes covered by Medicare will...
Breaking Medicine News(10 mins):Health News:Bipolar Disorder May Be Tied to Body Clock 2Health News:Organ Transplant Pioneers Celebrate Baylor Regional Transplant Institute's 25th Anniversary 2Health News:Organ Transplant Pioneers Celebrate Baylor Regional Transplant Institute's 25th Anniversary 3Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 2Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 3Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 4Health News:Really Big Coloring Books Debuts Bi-Lingual Spanish-English Line of Custom and Imprintable Coloring Books 2Health News:Diabetes cases to double and costs to triple by 2034 2Health News:Diabetes cases to double and costs to triple by 2034 3
... said that there is a sudden rise in the death rat...ed hospital superbug. // According to the latest f...actor in the deaths of people in National Health S... 2004, a rise of 213 from 2003. Murray Devin...
...ed in U.S among white and black girls regarding th...f adolescent girls to switch over to unhealthy sod... 2,371 girls had participated in the Growth Health...nine or ten year’s upto age 19. The records were t...
... ever, finds herself extremely attracted to Men ...se, according to research at St. Andrews Universit... vitality, good health and healthy genes, the comb...cho appeal, during the fertile phase. A Deep voice...
...have been blamed for not revealing vital data rega...e to the Government. // The health risks to worker...itted by George Washington University and Public C...ironmental Health journal. The carcinogeni...
...rres are involved in a unique kidney swap operatio...ut their blood types do not match. The same is the...dler's blood matches with Torres and his wife's wi...Medical Center. Around 80 paired-kidney swaps have...
...that they are staring human trials for testing the...or both HIV/AIDS as well as hepatitis B. The chemi... an extract from a Chinese herb called Inula brita... experiments back up initial findings, the compoun...
Other Medicine News:Health News:Rise in Deaths Rates Due To MRSA 2
...revolutionary MiniQuad, the DynaView 156 is design...ding to the ora serrata in both premature infants ...nd reduced 8.5mm contact element, the Volk DynaVie...rgery and is an absolute requirement for lens spar...
Iridectomy
... Super Macula® 2.2 offers extremely high resol...ea, while achieving an exceptionally wide 78° ...r critical evaluation of the optic nerve head and ... the macula and disc. Redesigned to reduce weight ...
...quator is designed for focal laser therapy and mid...tical design presents a realistic contour of the r...d view of the entire posterior pole extending to t...s dynamic movement on the globe, therefore increas...
Medicine Products: